Status:
COMPLETED
Caudal Dexmedetomidine Analgesia in Pediatrics .
Lead Sponsor:
Mansoura University
Conditions:
164 Boys for Hypospadias Surgery Under General Anesthesia With Caudal Block
Eligibility:
MALE
1-8 years
Phase:
NA
Brief Summary
Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has been used increasingly in pediatric anesthesia. This prospective double blinded randomized comparative study is designed t...
Detailed Description
Background: Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has been used increasingly in pediatric anesthesia. This prospective double blinded randomized comparative study i...
Eligibility Criteria
Inclusion
- 164 boys (age 1-8 years, ASA I) scheduled for hypospadias surgery
Exclusion
- Operative time exceeding 3 hours, bodyweight \>25kg, bleeding diathesis, infection at the site of block, pre-existing neurological or spinal disease or abnormalities of the sacrum, inability to palpate the sacral hiatus by anatomic landmark palpation technique) or those with a history of allergic reactions to local anesthetics were excluded from the study
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2020
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT03791879
Start Date
January 1 2019
End Date
October 15 2020
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anesthesia department,Faculty of medicine, Mansoura univerisety
Al Mansurah, Egypt